首页 / 院系成果 / 成果详情页

DECITABINE TREATMENT FOR ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 期刊论文

编号：

9de3edf1-0b1e-4ca1-8054-2215db508fae
作者：

Liu, XL.(刘晓亮)#^[1]Zhao, X.^[2];Wang, C.^[1];Gao, SJ.(高素君)^[1]Tan, YH.*^[1]
语种：

英文
期刊：

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS ISSN：0393-974X 2017 年 31 卷 1 期 (171 - 175) ; JAN-MAR
收录：
关键词：

AML allo-HSCT decitabine relapse
摘要：

Therapeutic options for patients with relapse of acute myeloid leukemia (AML) after allo-SCT are limited. Here, we present a case of a 49-year female with AML who underwent myeloablative allo-SCT from a matched sibling donor. Seven months after transplantation she developed cGVHD and suffered from extramedullary plus concurrent medullary relapse. The presence of CNS extramedullary disease is unique. Our patient was treated with decetabine. After one cycle the patient achieved complete remission and full donor chimerism without severe side effects or the occurrence of GVHD. Our case report, together with previous studies, provides strong evidence that decitabine may be a suitable treatment option for AML relapse after allogeneic transplantation, especially in patients who developed GVHD.
推荐引用方式
GB/T 7714：

Liu X-L.,Zhao X.,Wang C., et al. DECITABINE TREATMENT FOR ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION [J].JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS,2017,31(1):171-175.
APA：

Liu X-L.,Zhao X.,Wang C.,Gao S-J.,&Tan Y-H..(2017).DECITABINE TREATMENT FOR ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION .JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS,31(1):171-175.
MLA：

Liu X-L., et al. "DECITABINE TREATMENT FOR ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION" .JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS 31,1(2017):171-175.

浏览次数：23  下载次数：0

分享到：

浏览次数：23

下载次数：0

打印次数：0